Please note that this product was withdrawn from the Community Register of designated Orphan Medicinal Products in October 2019 on request of the Sponsor.
The sponsorship was transferred to Immune Design Ltd, United Kindom, in August 2016.
On 16 October 2017, orphan designation (EU/3/17/1924) was granted by the European Commission to Immune Design Ltd, United Kingdom, for glucopyranosyl lipid A stable emulsion (also known as G100) for the treatment of follicular lymphoma.
Glucopyranosyl lipid A
|Disease / condition||
Treatment of follicular lymphoma
|Date of first decision||
|EU designation number||
Review of designation
Sponsor's contact details
For contact details of patients’ organisations whose activities are targeted at rare diseases, see:
- European Organisation for Rare Diseases (EURORDIS), a non-governmental alliance of patient organisations and individuals active in the field of rare diseases.
- Orphanet, a database containing information on rare diseases, which includes a directory of patients’ organisations registered in Europe;